Lung mesenchymal expression of plays a critical role in tracheal development by unknown
Turcatel et al. BMC Biology 2013, 11:117
http://www.biomedcentral.com/1741-7007/11/117RESEARCH ARTICLE Open AccessLung mesenchymal expression of Sox9 plays a
critical role in tracheal development
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Background: Embryonic lung development is instructed by crosstalk between mesenchyme and epithelia, which
results in activation of transcriptional factors, such as Sox9, in a temporospatial manner. Sox9 is expressed in both
distal lung epithelium and proximal lung mesenchyme. Here, we investigated the effect of lung mesenchyme-
specific inducible deletion of Sox9 during murine lung development.
Results: Transgenic mice lacking Sox9 expression were unable to breathe and died at birth, with noticeable
tracheal defects. Cartilage rings were missing, and the tracheal lumen was collapsed in the mutant trachea. In situ
hybridization showed an altered expression pattern of Tbx4, Tbx5 and Fgf10 genes and marked reduction of
Collagen2 expression in the tracheal mesenchyme. The tracheal phenotype was increasingly severe, with longer
duration of deletion. Lymphatic vasculature was underdeveloped in the mutant trachea: Prox1, Lyve1, and Vegfr3
were decreased after Sox9 knockout. We also found that compared with normal tracheal epithelium, the mutant
tracheal epithelium had an altered morphology with fewer P63-positive cells and more CC10-positive cells, fewer
goblet cells, and downregulation of surfactant proteins A and C.
Conclusion: The appropriate temporospatial expression of Sox9 in lung mesenchyme is necessary for appropriate
tracheal cartilage formation, lymphatic vasculature system development, and epithelial differentiation. We
uncovered a novel mechanism of lung epithelium differentiation: tracheal cartilage rings instruct the tracheal
epithelium to differentiate properly during embryonic development. Thus, besides having a mechanical function,
tracheal cartilage also appears to be a local signaling structure in the embryonic lung.
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The development of the respiratory system represents
an evolutionary hallmark that allowed vertebrates to sur-
vive on land utilizing air as a source of oxygen. Abnormal
development of the respiratory system in humans is asso-
ciated with multiple disorders such as tracheal/bronchial
atresia, tracheo-esophageal fistula, bronchogenic cysts,
pulmonary/lobar atresia, and pulmonary hypoplasia [1].
In the embryonic trachea, the endoderm differentiates
into a ciliated pseudo-stratified epithelium, which includes
basal P63+ cells, Clara cells, neuroendocrine cells, and
ciliated cells. The ventral mesenchyme gradually matures* Correspondence: dwarburton@chla.usc.edu
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stated.to create C-shaped cartilage rings, while the dorsal mesen-
chyme forms contractile cells comprising the trachealis
smooth muscle, which defines the posterior boundary
between the trachea and esophagus. Tracheal wall malfor-
mation can be due to congenital or acquired abnormalities.
The congenital forms are related to immature tracheal
cartilage, whereas the more common acquired forms
occur as a consequence of compression damage or degen-
eration of the tracheal cartilage, such as in vascular sling
anomalies [2]. Tracheomalacia is a condition described as
causing excessive expiratory collapse of the trachea, resul-
ting from weakness of the supporting structures of tra-
cheal and bronchial walls, leading to symptoms of airway
obstruction [2,3].
β-catenin, Bmp4, and Shh are previously well-characterized
regulators of cartilage formation, which may activate the
Sox9 gene in mesenchymal cells to induce their differenti-
ation into chondrocytes. Members of the fibroblast growthl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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key regulators of cartilage formation [4,5]. Fgf18 regulates
proliferation and spatial localization of the chondrocytes
in the developing upper respiratory tract [6]. Tbx4 and
Tbx5 double knockout in lung resulted in defects of cartil-
age formation in mouse trachea and in altered lung
branching, with Tbx4 and Tbx5 acting upstream of Sox9
in tracheal cartilage development [7].
Here, we used an inducible Tbx4 gene-driven system
to knock out the Sox9 gene specifically in lung mesen-
chyme [8], in order to elucidate more fully its function
within the mesenchyme during lung development. Mes-
enchymal Sox9 knockout had no affect on distal lung
branching, on formation of smooth muscle around the
bronchi, or on the trachealis smooth muscle, whereas
tracheal cartilage formation was completely inhibited.
In situ hybridization revealed that in the Sox9 null tra-
chea, the characteristic Tbx4, Tbx5, and Fgf10 expression
pattern was lost or severely disrupted.
Mutant Sox9 mouse tracheal epithelium was also al-
tered: cells had a higher number of cytoplasmic vacu-
oles, with fewer basal cells (P63+ cells) and more Clara
cells (CC10+ cells). Mutant tracheal epithelium also had
fewer goblet cells compared with wild-type trachea.
Surfactant proteins A and C were also downregulated.
Finally, tracheal lymphatic vessels were significantly
underdeveloped after the knockout of mesenchymal Sox9.
In conclusion, mesenchymal Sox9-expressing cells cover a
critical developmental role in the formation of tracheal
cartilage rings, and in the appropriate differentiation of
lung tracheal epithelium and lymphatic system.
Results
Sox9 expression during lung development
We used western blot to analyze the expression of Sox9
in mouse lung during development. Sox9 protein ex-
pression level is high in embryonic lungs but drastic-
ally decreases in mouse lung after birth. Adult mouse
lung does not express Sox9 protein at all (Figure 1A).
At embryonic day (E)12.5, Sox9 is expressed by distal
lung epithelial cells and by a population of mesenchy-
mal cells surrounding the trachea, bronchi, and bron-
chioles. At E15.5, mesenchymal cells expressing Sox9
cells are condensed at the area of the future cartilage
rings, while epithelial cells expressing Sox9 are loca-
lized in the distal lung epithelium (Figure 1B). To
specifically knock out Sox9 in mesenchymal cells, we
used a Tbx4-rtTA/Tet-On-Cre system, in which rtTA
gene expression is regulated by the mesenchymal spe-
cific enhancer of the Tbx4 gene [8,9]. Tbx4 is expressed
by tracheal mesenchyme and most of the lung distal
mesenchyme (Figure 1C). Sox9 is efficiently deleted in
the Tbx4-rtTA/Tet-On-Cre/Sox9fl/fl at E12.5 and E15.5
stage (Figure 1D-I).Mesenchymal Sox9 knockout mice showed an absence of
tracheal cartilage rings
Perl reported that epithelial Sox9 deletion did not affect
lung development [10]. However, more recently, Chang
showed that Sox9 deletion in lung epithelium resulted in
a smaller lung, with fewer and dilated airway branches
[11]. It is possible that the use of different mouse genetic
backgrounds is the cause of these contrasting results.
The role of mesenchymal Sox9 expression is unknown.
In our study, transgenic mice lacking mesenchymal Sox9
expression were born at the expected mendelian fre-
quency and appeared normal at birth, but rapidly became
cyanotic and showed marked signs of respiratory obstruc-
tion including gasping and retractions (Figure 2A); more-
over, not a single transgenic mouse lived more than a few
hours after birth (Figure 2B). Despite the lethal respiratory
obstruction phenotype, no difference in weight at birth
was observed (Figure 2C). At both E15.5 and E18.5, em-
bryonic lung branching did not appear to be affected by
lack of mesenchymal Sox9 expression (Figure 2D,E; see
Additional file 1: Figure S1A-D). However, transgenic em-
bryos were missing cartilage rings around the trachea and
bronchi. (Figure 2F-I; see Additional file 1: Figure S1E,F).
Transverse sections of transgenic embryo E18.5 tracheas
showed collapsed airway lumen, and a shape and appear-
ance similar to esophagus; however, the esophagus was
still present. In 8% of the embryos, rudimentary cartilage
spots developed on the ventral side of the trachea (see
Additional file 2: Figure S2B black arrowheads). These
spots were still expressing Sox9 protein, indicating the ex-
istence of another unique population of Sox9+ cells that
either did not continue to express the Tbx4 gene or did
not express the transgene, or expressed the transgene, but
did not recombine (see Additional file 2: Figure S2C).
Lung branching was not affected by lack of mesenchyme
Sox9 expression (Figure 3A-C), and differentiation of dis-
tal lung epithelium and mesenchyme appeared to be nor-
mal in the mutants (Figure 3D-G).
The tracheal phenotype depends on the timing of
doxycycline exposure
The observed phenotype (Figure 2; see Additional file 1:
Figure S1) was obtained by knocking out the Sox9 gene
in the mesenchyme of the lung, starting from day E7.5
to the day of collection of the embryos (E18.5). We then
exposed pregnant time-mated females to different dura-
tions of doxycycline induction to determine the relation
between phenotype and doxycycline induction (Figure 4A).
Shorter exposure to doxycycline resulted in a milder
phenotype (Figure 4B-G), as embryos exposed to doxy-
cycline for shorter time periods developed some of the
more distal cartilage rings. If doxycycline was removed
from the food at E11.5, the two most proximal cartilage
rings were fully formed (Figure 4F,G, black arrows). Sox9
Figure 1 Expression of Sox9 during lung development. (A) Western blot analysis of Sox9 protein expression during lung development at
different stages (*non-specific bands). (B) Sox9 protein expression at E15.5 stage: immunofluorescence localization of Sox9 showed expression of
Sox9 by tracheal immature cartilage and distal lung epithelium. (C) Expression pattern of endogenous Tbx4 gene in E15.5 lung: Tbx4 is expressed
by tracheal mesenchyme and by most, but not all of the distal lung mesenchyme. (D-I) Sox9 immunostaining, showing effective deletion of
mesenchyme Sox-9 expression in the mutant lungs at embryonic day (D-G) E12.5 and (H, I) E15.5 stage. (J) Cell tracing using Tbx4-rtTA line.
Tbx4-rtTA/Tet-on-cre males were bred with mT/mG females. E7.5 staged pregnant females were fed with doxocycline, and E18.5 embryos were
collected. Lung epithelial cells expressed red fluorescent protein, while the mesenchyme cells are green because they are derived from
Tbx4-expressing cells (t, trachea; b, bronchus).
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lities in the cartilage development, as Tbx4 and Sox9 pro-
tein are not co-expressed in the tracheal mesenchyme at
that stage (Figure 4H-J).
Expression pattern of Tbx4, Tbx5, and Fgf10 is altered in
Sox9 mutant trachea
We next determined whether the expression pattern of
genes known to be involved in tracheal cartilage ring
formation was altered in the mutant trachea. Tbx4 and
Tbx5 are expressed between the tracheal cartilage rings
in normal mouse trachea [6]. In situ hybridization on
E15.5 embryonic lung tissue revealed that Tbx4 and
Tbx5 expression patterning was lost in the mutanttrachea (Figure 5A-D). Tbx4 and Tbx5 were expressed
uniformly by all the mesenchyme lining the trachea
(Figure 5B,D), instead of there being an alternating
striped pattern as observed in the control trachea
(Figure 5A,C). Using real-time reverse transcription
quantitative PCR (RT-qPCR) on RNA extracted from
E15.5 tracheas, we observed increased expression of
Tbx4 and Tbx5 in the mutant trachea versus the con-
trol trachea (Figure 5G). Fgf10 is another known key
regulator of tracheal cartilage development. The Fgf10
expression pattern in the E15.5 stage trachea normally de-
limits the primitive cartilage rings; however, this specific
expression pattern was lost after Sox9 knockout, and
Fgf10 was expressed by all the tracheal mesenchyme
Figure 2 Lung phenotype after mesenchymal Sox9 knockout. (A) Pups were collected at birth. Mutant pups died less than an hour after
birth, and showed gasping, retractions, and cyanosis. (B) Mutant pups did not survive post-natally. (C) Despite the respiratory mortality phenotype,
no change in weight at birth was observed between the wild-type pups and the mutant pups. (D-I) Samples of lung at embryonic day (E) 18.5 were
collected and analyzed. (E) Sox9Δ/Δ did not show obvious altered lung branching compared with (D) the control. (F, G) Alcian blue staining of
(F) E18.5 wild-type and (G) mutant lungs: normal tracheal rings were observed in the control normal lung, Sox9 knockout trachea revealed no tracheal
rings. (H, I) Transverse section of E18.5 trachea was stained with Alcian blue. (H) Wild-type and (I) mutant mice.
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Fgf10 mRNA expression in the mutant trachea but it was
not statistically significant.
Trachealis contractile muscle pattern formation and
bronchial smooth muscle cells are not affected by Sox9
knockout
The Tbx4, Tbx5, and Fgf10 expression patterns were lost
in Sox9 mutants. This observation led us to investigate
whether the Sox9 gene is also necessary for patterning the
SM-22-α + cells, which are located at the junction between
the trachea and esophagus (dorsal trachea), and form the
trachealis muscle. Because Sox9-expressing cells are lo-
cated at the ventral region of the trachea, Sm-22-α and
Sox9 expression seems to be mutually exclusive, sugges-
ting that expression of Sox9 is limiting the expression of
Sm-22-α to the dorsal area of the trachea, and vice versa.
However, we found that Sox9 expression is not involved
in patterning the expression of Sm-22-α-expressing cellsin the trachea (Figure 5F-K). In fact, the contractile lunar-
shaped ring of Sm-22-α + cells was still present and local-
ized in the dorsal area of the mutant trachea. The absolute
area covered by Sm22-α + cells did not change signifi-
cantly in the mutant trachea versus the wild-type trachea
(Figure 5J). We also analyzed whether the Sox9 gene was
involved in the proliferation of bronchial smooth muscle
cells; however, we did not observe any obvious change in
smooth muscle cells lining the bronchi of mutant mouse
lung (Figure 5L,M).
Tracheal epithelium is altered after Sox9 knockout
Mice lacking Sox9 in the lung mesenchyme died at birth,
due to an inability to breathe because of the collapsed
trachea. No change in smooth muscle cell numbers or
patterning was observed. However, the epithelium lining
the trachea was abnormal; epithelial cells in the mutant tra-
chea had larger and more numerous vacuoles (Figure 6B,F).
Electron microscopy revealed that some of those cells
Figure 3 Mesenchymal Sox9 deletion did not alter lung branching. (A, C) Left lobes of (A) wild-type and (B) mutant lung at embryonic day
(E) 15.5. Terminal branches were counted, and no difference in branching morphogenesis was identified. (D-G) Immunostaining for Sftpc, T1-αc,
and Pecam in E18.5 lungs confirmed that distal lung epithelium and mesenchyme differentiation were not altered by Sox9 deletion in the
lung mesenchyme.
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was used to quantify change of expression of lung-
relevant genes in mutant mouse trachea. Expression of the
surfactant protein genes Sftp-a and Sftp-c mRNA was re-
duced in the Sox9Δ/Δ mice, and CC10 mRNA was slightly
overexpressed in the mutant trachea (Figure 6H), indicat-
ing altered differentiation of tracheal epithelium. The
number of ciliated cells did not change after mesenchymal
deletion of the Sox9 gene (Figure 7A,B,G). However, at
E18.5, the number of tracheal basal cells (P63+) decreased
(Figure 7C,D,H) and Clara cells (CC10+) (Figure 7E,F,I)
increased in the mutant trachea versus the control tra-
chea. E15.5 Sox9fl/fl and Sox9Δ/Δ tracheas showed a similarnumber of P63+ cells (see Additional file 3: Figure S3).
Alcian blue staining of transverse sections of trachea re-
vealed decreased mucin production by the mutant tra-
cheal epithelium (Figure 6E,F). Agr2 protein, a marker of
lung goblet cells, was downregulated in the tracheal epi-
thelium of the Sox9Δ/Δ embryos compared with the Sox9fl/fl
embryos (Figure 7J-M). However, expression of Sox2 and
Foxp1, key regulators of lung epithelium differentiation,
was unaltered after Sox9 knock out (see Additional file 4:
Figure S4).
Despite the altered differentiation, proliferation of tra-
cheal epithelium was not affected by lack of mesenchy-
mal Sox9 expression, No change in phospho-histone-3
Figure 4 Doxycycline induction time length affects the severity of trachea phenotype in the Sox9 knockout lungs. (A) Time-plugged
female mice were fed with doxycycline for different time periods, and lungs were collected at embryonic day (E) 18.5. (B-G) Doxycycline induc-
tion from (B, C) E7.5 to E13.5, (D, E) E7.5 to E12.5, and (F, G) E7.5 to E11.5. (C, E, G) The severity of the phenotype in the transgenic embryos was
inversely correlated with the time length of induction. (B, D, F) No changes were observed in the wild-type lung tracheas. (H-J) E14.5 staged
pregnant females were fed with doxycycline. Embryos were harvested at E18.5, and the tissues fixed and stained with Alcian blue to show the
cartilage rings. (D) Normal cartilage rings developed in the trachea of the Sox9Δ/Δ embryos.
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tion was found (Figure 8A-E).
Tracheal lymphatic system was altered in Sox9Δ/Δ trachea
We quantified the area covered by lung mesenchyme
(excluding the cartilage) and the mesenchyme cell num-
ber on transverse sections of E18.5 wild-type and mutant
tracheas. Despite the somewhat misleading visual ap-
pearance, both the mesenchyme cell numbers and the
surface covered by them were the same in the Sox9fl/fl
and Sox9Δ/Δ trachea (Figure 9A-C,C′). Prox1 and Lyve1
are key markers of lymphatic vessel development [12].
Prox1 also controls neuronal progenitor cell differenti-
ation to maintain the required balance between different
cell types [13]. We found that the tracheal lymphatic
system was significantly underdeveloped in the mutant
Sox9 embryos, as shown by reduced immunostaining of
Prox1, Lyve1, and Pecam (Figure 9F-K). In addition, the,mRNA level of Prox1, Lyve1, and Vegfr3 was reduced in
the Sox9Δ/Δ tracheas (Figure 9l).
Discussion
Normal lung branching is achieved by tightly regulated
crosstalk between mesenchymal and epithelial compart-
ments. Specific growth factors are released from one
compartment to activate expression of genes in the other
compartment, and vice versa [14,15]. Sox9 is a multi-
functional transcriptional factor expressed in both em-
bryonic lung mesenchyme and epithelium. Perl et al.
reported that deletion of Sox9 gene in embryonic lung
epithelium did not affect lung development; mice lacking
Sox9 in the lung epithelium were viable and fertile, and
did not show any differences from their control litter-
mate, even when exposed to hyperoxia-induced injury
[10]. However, more recently, Chang et al. showed that
Sox9 is necessary for proper lung branching [11]. Sox9
Figure 5 Tbx4, Tbx5, and Fgf10 in situ hybridization results. In situ hybridization for (A, B) Tbx4 and (C, D) Tbx5 was performed on lung at
embryonic day (E) 15.5 to identify changes in expression patterns. Tbx4 andTbx5 were expressed by the mesenchyme surrounding the tracheal
rings in the normal control embryonic lung tracheas (A, C), whereas Sox9 knockout lungs displayed diffuse expression of (B) Tbx4 and (D) Tbx5
along all the tracheal mesenchyme. (E, F) The Fgf10 expression pattern was lost in the Sox9Δ/Δ trachea. (G) Real time RT-qPCR PCR was used to
determine whether expression of Tbx4 and Tbx5 mRNA was increased in the mutant mouse trachea versus wild-type mouse trachea (*P < 0.05). Fgf10
expression was not significantly different between by Sox9Δ/Δ vs. the Sox9fl/fl tracheas. (H-K) Trachealis smooth muscle cells did not change after Sox9
knockout. Staining for Sm-22-α was used to identify the trachealis smooth muscle cells on transverse sections of normal and transgenic mouse
tracheas. (J, K) Even though the absolute area of trachealis smooth muscle cells did not change, the Sm-22-α relative area was significantly
higher in the Sox9Δ/Δ (J) compared with (K) the Sox9fl/fl trachea, because of the smaller transversal area of the mutant trachea. **P = 0.015. Values are
mean ± SD, n = 5. (L, M). Staining for α-smooth muscle actin (α-SMA) was used to highlight smooth muscle cells. Sox9 deletion did not affect lung
smooth muscle cell proliferation or differentiation.
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branching [16]. These contrasting reports on Sox9 regu-
lation of lung epithelial lung branching may be due to
the use of different mouse genetic backgrounds by Perl
and Chang. Here, we focused on the role of the mesen-
chymal Sox9-expressing cells, which are localized around
the trachea and main bronchi. By using an inducible
doxycycline-regulated system, driven by part of the Tbx4gene promoter [8], we were able to delete Sox9 expression
specifically in the mesenchymal compartment of the
murine lung. Our collaborator Shi [9] developed the
Tbx4-rtTA transgenic mouse line and in the present
study, we showed that this mouse line specifically deleted
Sox9 in lung mesenchyme (Figure 1D-I) and likewise acti-
vated a green fluorescent protein (GFP) reporter gene in
lung mesenchyme (Figure 1J).
Figure 6 Lung tracheal epithelium is altered in Sox9 knockout mice. (A-B) Hematoxylin and eosin (H&E) staining of embryonic day (E) 18.5
tracheal sections, showing altered morphology of epithelial cells in (B) the mutant trachea compared with (A) the wild-type (A′ and B′ are high
magnification inserts of A and B respectively). (C, D) Intralobar sections of main bronchi stained with H&E. No obvious differences are seen
between (C) the wild-type and (D) mutant intralobar bronchia. (E, F) Transverse sections of (E) wild-type and (F) mutant mouse tracheas stained
with Alcian blue. Mutant tracheas are collapsed because of the lack of structural support normally given by the cartilage rings. (G) Electron
microscopy of epithelial cells lining the mutant tracheal revealed the presence of Clara cells. (H) Real time RT-qPCR analysis at E18.5 altered
expression of Sftpc, Sftpa, and CC-10 genes. *P < 0.05, **P < 0.01. Values are mean ± SD.
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rings, were unable to breathe because of tracheal col-
lapse, and died shortly after birth. Transgenic mice
appeared normal at birth, but then rapidly showed
clear evidence of cyanosis (Figure 2A), and not a sin-
gle transgenic pup lived more than a few hours after
birth (Figure 2B), despite the birth weights of the mu-
tants being similar to those of wild-type mice (Figure 2C).
These data suggest that lack of mesenchymal Sox9 in em-
bryonic lung is not compatible with life.
Arora et al. obtained a similar but milder tracheal car-
tilage phenotype in transgenic mice missing both the
Tbx4 and Tbx5 genes; some cartilage trachea rings still
developed, but they were smaller and had an abnormal
shape [7]. A Tbx4 and Tbx5 combined deletion also re-
sulted in altered lung branching. Data from the samelaboratory also suggested that Tbx4 and Tbx5 are up-
stream regulatory genes of Sox9 in the embryonic lung
mesenchyme [7].
Lung mesenchyme Sox9 knockout mice did not show
an obvious phenotype on lung branching; the number
of terminal branches of the left lobe of E15.5 lungs
was not different between the wild-type and mutant
embryos (Figure 3A-C). Moreover, differentiation of dis-
tal lung epithelium and mesenchyme was not affected
by lack of Sox9 mesenchymal expression at E18.5
(Figure 3D-G). Thus, Sox9 deletion appears to affect
only tracheal development.
In our mesenchyme-specific Sox9 knockout model,
Tbx4 and Tbx5 expression was enhanced in the trachea.
This indicates the existence of a complex feedback
from Tbx4/5 to Sox9 and vice versa. Thus, Tbx4/5 gene
Figure 7 Basal cell numbers are decreased and Clara cell numbers are increased in the mutant mouse trachea. (A-B) Ciliated cell number
was not altered in Sox9 knockout mouse tracheas. Staining for β-tubulin-IV on transverse section of wild-type and mutant mouse trachea was
used to determine change in ciliated cell numbers. (G) The number of ciliated cells did not change in the mutant mouse trachea versus the
wild-type mouse trachea. (C, D) Staining for P63 was used to confirm that the number of basal cells is decreased in the mutant mouse trachea.
(E, F) CC10 marker staining was used to highlight the increase in Clara cell number in Sox9 mutant mouse trachea. (G-I) Cell count statistics.
*P <0.03. Values are mean ± SD, n = 4. (J-M) Sox9Δ/Δ tracheas had a reduced number of goblet cells. (J, K) Immuno-fluorescence staining and
(L) western blot for Agr2 protein were used to determine change in goblet cells after Sox9 knockout. Sox9 knockout resulted in reduced production
of Agr2 by the tracheal epithelium, suggesting reduced numbers of goblet cells in the Sox9Δ/Δ trachea. (M) Intensity analysis of Western blot bands.
**P < 0.05. Values are mean ± SD.
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partially compensated for the lost Sox9 expression in our
mutant.
Moreover, Sox9 knockout mice also had an altered
Tbx4/5 pattern of expression. In normal lung trachea,
the Tbx4 and Tbx5 genes are expressed by the mesen-
chyme in the intervals between the developing cartilage
rings. Thus, the Tbx4/5 genes and the Sox9 gene are
normally mutually exclusive in the tracheal mesenchymeat E15.5. When the Sox9 gene was knocked out, the
Tbx4/5 genes were uniformly expressed by all the mes-
enchyme surrounding the trachea. A similar result was
obtained with Fgf10 pattern expression. At E15.5, Fgf10
is normally expressed by the developing cartilage rings
in the trachea. Inactivation of Sox9 resulted in the dis-
ruption of the normal Fgf10 spatial expression pat-
tern; Fgf10 was now expressed by all the mesenchyme
surrounding the trachea. Quantification of the mRNA
Figure 8 Tracheal epithelial differentiation and apoptosis was not altered by lack of Sox9 gene. (A, B) Phospho-histone-3 (pH3) staining
on longitudinal sections of (A) wild-type and (B) mutant tracheas at embryonic day (E) 15.5 did not reveal any change in epithelial cell proliferation.
(C) Number of pH3-positive cells per section was similar between wild-type and mutant mouse trachea. (D) Real-time PCR for the apoptotic markers
p53, Bcl2, and Gadd45a on total RNA extracted from E15.5 wild-type and mutant tracheas indicated no change in apoptosis. (E) Tracheal epithelial cells
were counted on transverse sections of Sox9fl/fl and Sox9Δ/Δ E18.5 tracheas, revealing no change in cell number between the two groups. Values
are mean ± SD.
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mRNA level, but this did not reach statistical significance.
Taken together, these data clearly indicate that the
Sox9 gene has a key role in patterning the expression of
Tbx4/5 and Fgf10 in the embryonic trachea. Genes link-
ing Sox9 expression to Tbx4/5 and Fgf10 gene expres-
sion pattern will be the subject of future studies.
The Tbx4-rtTA inducible system allowed us to closely
regulate the timing of Sox9 deletion. We took advantage
of this to investigate how the length of time of doxycyc-
line induction relates to the severity of the phenotype.
We found that shorter induction resulted in a milder
phenotype. If the doxycycline was removed from the
food at E11.5, the two most distal cartilage rings formedfully (Figure 4G), but in these mice, the Tbx4 gene was
expressed by all the lung mesenchyme [7], which implies
that all lung mesenchymal cells in these mice have a
non-functional Sox9 gene at that stage. There are several
possible explanations for these results. It could be that
mesenchymal Sox9-positive cells are continuously mi-
grating from the laryngeal region into the tracheal mes-
enchyme to contribute to cartilage ring formation, or
that the shorter doxycycline exposure results in incom-
plete Sox9 deletion. Another possible explanation is that
Tbx4-rtTA is expressed in distal mesenchyme and then
proceeds towards the larynx over time. Future studies
involving the use of a Sox9-ER-cre mouse line in com-
bination with our Tbx4-rtTA model should be able to
Figure 9 (See legend on next page.)
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Figure 9 Lymphatic vascular system was affected by Sox9 deletion. (A-C) Tracheal mesenchyme area quantification analysis did not reveal
changes between the wild-type and mutant tracheas (tracheal mesenchyme was stained in black). (C′) The number of mesenchymal cells per
section was similar between wild-type and mutant trachea. (D, E) Real time RT-qPCR for Collagen2, Gli1, and Shh on mRNA from wild-type and
mutant tracheas at embryonic day (E) 15.5. Col2 expression was decreased in the Sox9Δ/Δ trachea starting at E15.5 stage. No statistically significant
differences in expression of Shh, Gli1, Gli2, or Gli3 was observed between Sox9fl/fl and Sox9Δ/Δ. (F-L) The lymphatic vascular system was underdeveloped
in the mutant trachea. Immunostaining of the lymphatic markers (F, G) Lyve1, (H, I) Prox1, and (J, K) Pecam revealed that Sox9 deletion resulted in
impaired lymphatic vessel formation. (L) Real time RT-qPCR for Prox, Lyve1, and Vegfr3 confirmed that the lymphatic vascular system was not properly
developed in the Sox9 knockout tracheas. *P < 0.05, **P = 0.08.
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one. However, considering that Sox9 is also expressed by
neural crest cells [17,18], which are ‘migratory’ cells, the
hypothesis of Sox9 continuously migrating into the lung
mesenchyme seems to be the most plausible, and it will
be the first hypothesis to be tested in our future studies.
By E14.5 to E15.5, tracheal Tbx4 and Sox9 are mutually
exclusively expressed, thus as predicted, knockout of the
Sox9 gene atat this later stage (E14-5 to E15-5) did not
affect tracheal cartilage development (Figure 4). The
ability to regulate the severity of the tracheal phenotype
will allow us to tailor timed knockouts to model specific
tracheal and lung disease models for future studies.
As pointed out above, mesenchymal-epithelial crosstalk
is required for correct development of the embryonic
lung. Therefore, anatomical or molecular alterations of
one embryonic compartment such as mesenchyme may
affect the correct development of the epithelia, and vice
versa. We noticed that the tracheal epithelium was altered
after mesenchymal Sox9 knockout. Cell count analysis re-
vealed that mutant trachea had a lower number of basal
P63+ cells, and a higher number of Clara (CC10+) cells.
The number of ciliated cells did not change. An immedi-
ate conclusion would be that the absence of cartilage rings
around the embryonic trachea caused the tracheal epithe-
lium to behave more similarly to the more distal intralobar
bronchiolar epithelium. As the number of basal cells was
not altered in the E15.5 Sox9Δ/Δ trachea, we suggest that
basal cell differentiation is not directly dependent on Sox9
expression but is more likely to depend on cartilage con-
densation, which normally starts to occur at E15.5. Thus,
we speculate that a specific growth factor signal (or sig-
nals) may be released by the cartilage rings to promote
correct tracheal epithelium differentiation.
Sox9Δ/Δ trachea had reduced production of Agr2, a
protein that identifies goblet cells in the lung. Moreover,
transcripts of both surfactant proteins A and C were re-
duced in the mutant trachea, further supporting the role
of Sox9 expressing cells in the differentiation of tracheal
epithelium.
Despite the altered differentiation, proliferation of tra-
cheal epithelium was not affected by lack of mesenchy-
mal Sox9 expression. No change in pH3 or epithelial cell
number per transversal section was found (Figure 8A-E).Thus, lack of tracheal rings altered proper differentiation
of tracheal epithelium but not its proliferation.
The expression pattern of Fgf10 in Sox9Δ/Δ embryonic
trachea was markedly altered. Even though it was not sta-
tistically significant, Fgf10 mRNA level was slightly de-
creased in the mutant trachea. Volckaert et al. [16] showed
that Fgf10 overexpression resulted in an increased number
of basal cells and decreased number of Clara cells [19]. Be-
cause of the concordance of these and our results, we
hypothesize that incorrect expression of Fgf10 may be
mostly responsible for the altered differentiation of tracheal
epithelium in the Sox9Δ/Δ trachea. We cannot conclude
without any doubt that the epithelial phenotype is directly
related to the absence of signals originating from the cartil-
age rings. An alternative plausible model is that the lack of
mechanical support (and thus collapse) of the trachea
instructs the epithelium to differentiate onto a different
path. Finally, the lack of proper vasculature development
(discussion below) in the mutant trachea may also contri-
bute to the altered differentiation of the tracheal epithelium.
Gli2–/–,Gli3+/– mutants displayed esophageal atresia with
tracheo-esophageal fistula and a severe lung phenotype [20].
Gli2 and Gli3 gene expression in the Sox9Δ/Δ trachea did not
change in our Sox9 knockout model (Figure 9E). Shh and
Gli1 are also key regulators of cartilage development [21],
but their expression was not altered in our Sox9Δ/Δ emb-
ryonic trachea (Figure 9E). Expression of Collagen2, a key
regulator of cartilage differentiation, was reduced after Sox9
deletion, supporting the model in which Sox9 acts upstream
of Collagen2 to control tracheal cartilage development.
Despite the somewhat misleading visual appearance, the
numbers of mesenchymal cells and the area covered by them
were not different between the Sox9fl/fl and Sox9Δ/Δ trachea
(Figure 9A-C,C′). Thus, the apparent difference in size ob-
served between the wild-type and mutant tracheas is caused
by the lack of the cartilage rings in the Sox9Δ/Δ trachea.
Pecam is broadly expressed by vascular structures [22,23].
and its expression in the distal lung mesenchyme was
assayed to investigate any alterations of distal mesenchyme
lung differentiation. As we observed for the distal epithelium,
the distal lung mesenchyme appeared normal in the mutant
trachea. We concluded that lack of Sox9 in the lung mesen-
chyme did not affect the differentiation or development of
the vasculature in the distal lung mesenchyme.
Figure 10 Concept diagram of Sox9 function in lung
development. Sox9 acts downstream of Tbx4/5 [6]. Sox9 feeds back
negatively on Tbx4 and Tbx5 in the tracheal mesenchyme. Cartilage
ring formation requires functional Sox9 expression in the tracheal
mesenchyme. Lack of cartilage rings induce altered tracheal
epithelium differentiation (increased Clara cells, and decreased basal
and goblet cells) and defective development of tracheal
vasculature structurest.
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fluid, extravasated plasma proteins, and cells back to the
circulation [24,25]. Prox1 and Lyve1 are key regulators and
markers of lymphatic vessel development. The lymphatic
system was significantly underdeveloped in the mutant
Sox9 tracheas; immunostaining of Prox1, Lyve1, and Pecam,
and mRNA level of Prox1, Lyve1, and Vegfr3 were reduced
in the Sox9Δ/Δ tracheas. Thus, lack of tracheal cartilage af-
fects appropriate tracheal lymphatic vessel development. It
is also possible that an early Sox9-expressing mesenchymal
cell population exists, and that this differentiates into
lymphatic vessel cells. As Pecam is expressed by both blood
and lymphatic vascular vessels, we speculate that mesen-
chymal Sox9 expression has a broad role in the generalized
vascularization of the trachea. The mechanism linking the
lack of cartilage rings to the altered tracheal vascularization
is under further investigation. We focused on epidermal
growth factor, as it is known to be involved in lymphatic
vessel modeling in the skin [26], and found it to be down-
regulated in the Sox9Δ/Δ trachea (data not shown).
Conclusions
In conclusion, we have uncovered a key fundamental role
of the mesenchymal Sox9-expressing cells in the develop-
ment of the tracheal cartilage rings, which in turn induce
proper tracheal epithelium differentiation and lymphatic
system development (Figure 10). Thus, besides having a
mechanical function, tracheal cartilage also appears to be
a local signaling structure in the embryonic lung. Some
pieces of this puzzle are still missing, and are currently
under investigation. Nevertheless, we have identified an
important mechanism by which mesenchymal Sox9-
expressing cells instruct tracheal cartilage, epithelial, and
lymphatic differentiation in a phenotype that already ap-
pears to model and may perhaps explain mechanistically
some extreme cases of primary tracheomalacia in human
new born infants.
The appropriate temporospatial expression of Sox9 in
lung mesenchyme is necessary for correct tracheal cartil-
age formation, lymphatic vasculature system development,
and epithelial differentiation. Our study showed that a lack
of tracheal cartilage rings resulted in increase in Clara cells
and decrease in basal and goblet cells in the tracheal epi-
thelium. We also uncovered a novel mechanism of lung
epithelium differentiation; tracheal cartilage rings instruct
the tracheal epithelium to differentiate properly during
embryonic development. Thus, besides having a mecha-
nical function, tracheal cartilage also appears to be a local
signaling structure in the embryonic lung.
Methods
Ethics statement
We strictly followed the National Institute of Health
guidelines for animal care and safety. The animalexperimental protocols were approved by the Animal
Care and Use Committee at the Children’s Hospital Los
Angeles (CHLA), where the vivarium is under weekly
surveillance by an external chief veterinarian to check
animal health. Our animal facility is approved by the
AAALAC (Association for Assessment and Accredi-
tation of Laboratory Animal Care) and USDA (The
United States Department of Agriculture).
Mice
Sox9fl/fl mice were bought from Jackson Laboratories
(Sacramento, CA). Tbx4-rtTA mice were kindly pro-
vided by W Shi (CHLA) [9]. The plasmid bearing the
lung-specific enhancer of Tbx4 was kindly provided by
D B Menke (University of Georgia) [8]. Tet-On-Cre mice
were bought from Jackson Laboratories. Mt/mG mice
(stock number 007576) were bought from Jackson Labora-
tories. Tbx4-rtTA/Tet-on-cre mice were generated and
crossed with female Sox9fl/fl. Timed pregnant mice were
fed with doxycycline chow (rodent diet with 0.0625%
doxycycline; Harlan Teklad TD01306) from E7.5 stage,
unless specified.
Alcian blue staining
Alcian blue staining was performed in accordance with
standard protocols. Lungs and trachea were dissected
out at different stages of life, and fixed in 95% ethanol
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washed with 95% ethanol for 1 to 2 days, and finally
clarified in 1% potassium hydroxide solution for 2 to 5
hours [5]. For Alcian blue staining on tissue sections, 5
μm thick paraffin wax-embedded sections were rehy-
drated, stained with 1% Alcian blue in 3% acetic acid for
30 minutes, washed in distilled water, and counter-
stained with Nuclear Fast Red.
Whole-mount in situ hybridization
E15.5 lungs were isolated from embryos and fixed for 2
hours in 4% paraformaldehyde in phosphate-buffered sa-
line (PBS). The samples were washed twice in PBS for
5 minutes, transferred to 70% ethanol overnight, and
stored in 100% ethanol until needed. Whole-mount in situ
hybridization was performed as previously described,
with riboprobes transcribed from murine plasmid DNA
templates [5].
Immunohistochemistry and histology
Immunohistochemistry and immunofluorescence were
performed on 5 μm thick paraffin wax-embedded sections,
as described previously. Primary antibodies used were
anti-Sm22-α, P63, Sox9, CC10 (Santa Cruz Biotechno-
logy), anti-Tubb4 (BioGenex), (Developmental Studies
Hybridoma Bank antibody 8.1.1), anti-Agr2 (Abgent),
anti-phospho-H3, β-catenin (Cell Signaling Technology,
Danvers, MA), α-SMA (Sigma-Aldrich), anti-PECAM
(LifeSpan Bioscences Inc.), anti-Prox1, and Lyve1 (both
Angiobio). The Alexa Fluor 488, 555, and 647 secondary
antibodies were from Invitrogen.
For histological evaluation, embryos were removed from
the uterine horns, and dissected free from the decidua, then
the lungs were removed and fixed in 4% formalin at room
temperature. After dehydration in ethanol, embryos were
embedded in paraffin wax, sectioned at 5 μm thickness and
stained with hematoxylin and eosin or Alcian blue.
cDNA reverse transcription and real-time reverse
transcription PCR
Total RNA was extracted from mouse tracheas using
Trizol reagent, then 500 to 1,000 ng of RNA was
reverse-transcribed using the IscriptcDNA synthesis
kit (Bio-Rad, Hercules, CA, USA). RNA was extracted
from a pool of three tracheas to get sufficient good-
quality RNA for expression analysis. Real-time quanti-
tative PCR was performed in a Lightcycler II (Roche
Applied Science) using gene-specific primers (Operon,
Huntsville, AL, USA) and fluorescence probes (Roche
Applied Science).
Western blot
Embryos were dissected in cold PBS, tracheas were sepa-
rated from the esophagus and lysed with RIPA buffer(1 × Tris-buffered saline, 1% Nonidet P-40, 0.5% so-
dium deoxycholate, 0.1% SDS, 0.004% sodium azide;
Sigma-Aldrich, St. Louis, MO, USA), supplied with phos-
phatase and protease inhibitors (phenylmethylsulfonyl
fluoride (PMSF) solution, sodium orthovanadate solution,
and protease inhibitor cocktail solution; Sigma-Aldrich).
Three tracheas from each experimental group (wild-type
and control) were combined together to achieve a suffi-
cient amount of protein lysate. β-actin protein amount
was used as loading control and measured in each western
blot experiment.
Cell count and cellular area analysis
A Leica confocal microscope (Leica) was used to capture
fluorescent images. For epithelial and mesenchymal cells
counts, (Figure 8C, Figure 9C), 4 μm thick tracheal
transversal sections were used; nuclei were highlighted
with DAPI or hematoxylin, and counted with ImageJ
software.
For mesenchymal area analysis, the mesenchyme area
on transversal sections of tracheas was highlighted, and
pixels were counted using Photoshop software.
Statistical analysis
The student’s t-test was used to perform statistical ana-
lysis. Every experiment was repeated at least three times
unless indicated.Additional files
Additional file 1: Figure S1. Lung phenotype after Sox9 knockout at
embryonic day (E) 15.5. (A-D) Bright-field and dark-field pictures of (A, C)
wild-type and (B, D) mutant Sox9 knockout mouse lungs. (E, F) Alcian
blue staining of longitudinal sections of (E) wild-type and (F) mutant Sox9
knockout mouse trachea. C′ and D′ are high magnification pictures of C
and D, respectively.
Additional file 2: Figure S2. Incomplete phenotype in Sox9Δ/Δ trachea.
(A, B) A small percentage of the Sox9Δ/Δ lung developed proximal
rudiments of cartilage in the ventral side of trachea. (C) Transverse
section of lung in (B) stained for Sox9.
Additional file 3: Figure S3. Staining for P63 was used to determine
changes in basal cells in E15.5 Sox9Δ/Δ trachea compared with Sox9fl/fl
trachea. (A-C) Number of P63-positive cells in the tracheal epithelium was
not affected by Sox9 deletion at embryonic day (E) 15.5.
Additional file 4: Figure S4. Sox2 and Foxp1 expression was not
altered in Sox9Δ/Δ tracheal epithelium. Immunofluorescence staining for
Sox2 and Foxp1 did not show any qualitative or quantitative alterations
of expression of these transcriptional factors in the mutant trachea.Competing interests
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